{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:57:45Z","timestamp":1790225865468,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.dld.2016.03.018","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T16:14:33Z","timestamp":1459700073000},"page":"780-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie \u2013 GISC"],"prefix":"10.1016","volume":"48","author":[{"given":"Cesare","family":"Mazzaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Dal Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Urraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endri","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Castelnovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Casarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-4166","authenticated-orcid":false,"given":"Anna Linda","family":"Zignego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Pozzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2016.03.018_bib0205","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection \u2013 natural history and clinical consequences","volume":"350","author":"Gamen","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0210","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0140-6736(93)92250-W","article-title":"Clinical aspects of hepatitis B virus infection","volume":"342","author":"Wright","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2016.03.018_bib0215","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2005.05.029","article-title":"Hepatitis B virus genotypes and extrahepatic manifestations","volume":"43","author":"Cacoub","year":"2005","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.rdc.2009.03.006","article-title":"Hepatitis B-related autoimmune manifestations","volume":"35","author":"Cacoub","year":"2009","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1016\/j.dld.2016.03.018_bib0225","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/rheumatology\/40.9.1064","article-title":"Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent","volume":"40","author":"Filer","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00004836-200305000-00020","article-title":"Successful treatment of hepatitis B-associated vasculitis with lamivudine","volume":"36","author":"Stecevic","year":"2003","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2016.03.018_bib0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-140-8-200404200-00035","article-title":"Remission of hepatitis B virus-related vasculitis with lamivudine","volume":"140","author":"Sawabe","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0240","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7326\/0003-4819-149-12-200812160-00019","article-title":"Entecavir to treat hepatitis B-associate cryoglobulinemic vasculitis","volume":"149","author":"Enomoto","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0245","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/039463200902200231","article-title":"Successful lamivudine monotherapy in an elderly patient suffering from HBV-related decompensated cirrhosis associated with widespread leukocytoclastic vasculitis","volume":"22","author":"Conca","year":"2009","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"10.1016\/j.dld.2016.03.018_bib0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2012.10.014","article-title":"Tellbivudine in treatment of hepatitis B-associated cryoglobulinemia","volume":"56","author":"Boglione","year":"2013","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.dld.2016.03.018_bib0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000355778","article-title":"HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with Entecavir","volume":"39","author":"Vigano","year":"2014","journal-title":"Kidney and Blood Pressure Research"},{"key":"10.1016\/j.dld.2016.03.018_bib0260","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryo globulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0265","first-page":"79","article-title":"Mixed cryoglobulinemia cross-reactive idiotypes: implication for the relationship of MC to rheumatic and lymphoproliferative diseases","volume":"28","author":"Gorevicc","year":"1991","journal-title":"Seminars in Hematology"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2016.03.018_bib0270","first-page":"SII20","article-title":"HCV and cryoglobulinemic vasculitis","volume":"69","author":"Ferri","year":"2002","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0275","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2016.03.018_bib0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"Johnson","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1681\/ASN.V62220","article-title":"Hepatitis C virus infection and membrano-proliferative glomerulonephritis in Japan","volume":"6","author":"Yamabe","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.dld.2016.03.018_bib0290","first-page":"813","article-title":"Therapy of hepatitis C virus associated glomerulonephritis: current approaches","volume":"21","author":"Fabrizi","year":"2008","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.dld.2016.03.018_bib0295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal disease","volume":"4","author":"Perico","year":"2009","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.dld.2016.03.018_bib0300","first-page":"933","article-title":"Efficacy and safety of peginterferon alpha-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study","volume":"29","author":"Mazzaro","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0305","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected 215 patients","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.dld.2016.03.018_bib0310","first-page":"101","article-title":"Efficacy and safety of rituximabin type II mixed cryoglobulinemia","volume":"15","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.dld.2016.03.018_bib0315","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.dld.2016.03.018_bib0320","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/17474124.2015.1075391","article-title":"Non-invasive assessment of liver fibrosis and prognosis","volume":"9","author":"Hagan","year":"2015","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0325","first-page":"1775","article-title":"Interferon-alpha plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon","volume":"30","author":"Mazzaro","year":"2003","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0330","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2169\/internalmedicine.45.1816","article-title":"Successful treatment with Adefovir of one patient whose cryoglobulinemic vasculitis relapsed under Lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations","volume":"45","author":"Cakir","year":"2006","journal-title":"Internal Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0335","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long term predictors of survival in 209 essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney International"},{"key":"10.1016\/j.dld.2016.03.018_bib0340","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2796.2000.00627.x","article-title":"Hepatitis C virus risk: a hepatitis C virus related syndrome","volume":"247","author":"Mazzaro","year":"2000","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0345","doi-asserted-by":"crossref","first-page":"c41","DOI":"10.1159\/000324652","article-title":"Treatment of hepatitis B virus-associated nephropaty","volume":"119","author":"Elewa","year":"2011","journal-title":"Nephron Clinical Practice"},{"key":"10.1016\/j.dld.2016.03.018_bib0350","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.clinre.2012.03.033","article-title":"Complete remission of hepatitis B virus related membranous nephropaty after Entecavir monotherapy","volume":"36","author":"Yang","year":"2012","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.dld.2016.03.018_bib0355","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","article-title":"Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids","volume":"45","author":"Quartuccio","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0360","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20244 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.dld.2016.03.018_bib0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0370","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.510290321","article-title":"Efficacy of lamivudine in patients with hepatitis B e antigen-negative\/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group","volume":"29","author":"Tassopoulos","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0375","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir Dipivoxil 438 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2016.03.018_bib0380","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2009.03.006","article-title":"Peginterferon alfa-2a in HBeAg-negative Chronic Hepatitis B Study Group. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a","volume":"136","author":"Marcellin","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2016.03.018_bib0385","first-page":"S336","article-title":"Increasing rates of HBsAg clearance and seroconversion in patients with HBeAg-negative disease treated with peginterferon alfa-2A\u00b1lamivudine: results of 5-year post-treatment follow up","volume":"50","author":"Marcellin","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2016.03.018_bib0390","first-page":"1011A","article-title":"Five years of treatment with tenofovir DF (TDF) for chronic hepatitis B (CHB) infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis","volume":"54","author":"Marcellin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.03.018_bib0395","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Adefovir Dipivoxil 438 Study Group. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2016.03.018_bib0400","first-page":"1559","article-title":"Successful treatment of hepatitis B virus infection and related cryoglobulinemic purpura with nucleotide analogues","volume":"31","author":"D\u2019Amico","year":"2013","journal-title":"Clinical and Experimental Rheumatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815303480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815303480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:26Z","timestamp":1655424026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865815303480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1590865815303480"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2016.03.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie \u2013 GISC","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2016.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}